Innovent Biologics (HK:1801) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovent Biologics has announced the grant of share options and restricted shares to certain employees under its 2024 Share Scheme. A total of 170,600 share options were granted to six grantees, and 683,400 restricted shares were granted to 16 grantees, all of whom are non-senior staff. These grants are subject to performance targets and have a clawback mechanism in case of misconduct or termination for cause.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.